BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 33851215)

  • 21. Efficacy and safety of, and patient satisfaction with, colonoscopic-administered fecal microbiota transplantation in relapsing and refractory community- and hospital-acquired Clostridium difficile infection.
    Khan MA; Sofi AA; Ahmad U; Alaradi O; Khan AR; Hammad T; Pratt J; Sodeman T; Sodeman W; Kamal S; Nawras A
    Can J Gastroenterol Hepatol; 2014 Sep; 28(8):434-8. PubMed ID: 25014180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
    Tariq R; Disbrow MB; Dibaise JK; Orenstein R; Saha S; Solanky D; Loftus EV; Pardi DS; Khanna S
    Inflamm Bowel Dis; 2020 Aug; 26(9):1415-1420. PubMed ID: 31821444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superiority of Higher-Volume Fresh Feces Compared to Lower-Volume Frozen Feces in Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Colitis.
    Agarwal A; Maheshwari A; Verma S; Arrup D; Phillips L; Vinayek R; Nair P; Hagan M; Dutta S
    Dig Dis Sci; 2021 Jun; 66(6):2000-2004. PubMed ID: 32656604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.
    Cheng YW; Phelps E; Ganapini V; Khan N; Ouyang F; Xu H; Khanna S; Tariq R; Friedman-Moraco RJ; Woodworth MH; Dhere T; Kraft CS; Kao D; Smith J; Le L; El-Nachef N; Kaur N; Kowsika S; Ehrlich A; Smith M; Safdar N; Misch EA; Allegretti JR; Flynn A; Kassam Z; Sharfuddin A; Vuppalanchi R; Fischer M
    Am J Transplant; 2019 Feb; 19(2):501-511. PubMed ID: 30085388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis.
    Porcari S; Severino A; Rondinella D; Bibbò S; Quaranta G; Masucci L; Maida M; Scaldaferri F; Sanguinetti M; Gasbarrini A; Cammarota G; Ianiro G
    J Autoimmun; 2023 Dec; 141():103033. PubMed ID: 37085337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis.
    Ramai D; Zakhia K; Fields PJ; Ofosu A; Patel G; Shahnazarian V; Lai JK; Dhaliwal A; Reddy M; Chang S
    Dig Dis Sci; 2021 Feb; 66(2):369-380. PubMed ID: 32166622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Vaughn BP; Fischer M; Kelly CR; Allegretti JR; Graiziger C; Thomas J; McClure E; Kabage AJ; Khoruts A
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1330-1337.e2. PubMed ID: 36126907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five years of fecal microbiota transplantation - an update of the Israeli experience.
    Greenberg SA; Youngster I; Cohen NA; Livovsky DM; Strahilevitz J; Israeli E; Melzer E; Paz K; Fliss-Isakov N; Maharshak N
    World J Gastroenterol; 2018 Dec; 24(47):5403-5414. PubMed ID: 30598584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection.
    Saha S; Mara K; Pardi DS; Khanna S
    Clin Infect Dis; 2021 Oct; 73(7):e1706-e1712. PubMed ID: 32976567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospitalized Older Patients with
    Shin JH; Hays RA; Warren CA
    Adv Geriatr Med Res; 2021; 3(2):. PubMed ID: 34263258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal microbiota transplantation for recurrent Clostridioides difficile infection.
    Haber SL; Raney CRK; Larson TL; Lau JP
    Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.
    Cheng YW; Alhaffar D; Saha S; Khanna S; Bohm M; Phelps E; Ghabril M; Orman E; Sashidhar S; Rogers N; Xu H; Khoruts A; Vaughn B; Kao D; Wong K; Cammarota G; Ianiro G; Dhere T; Kraft CS; Mehta N; Woodworth MH; Allegretti JR; Nativ L; Marcus J; El-Nachef N; Fischer M
    Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1627-1634. PubMed ID: 32645451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of Fecal Microbiota Transplantation for First Recurrent Clostridioides difficile Infection.
    Aby ES; Vaughn BP; Enns EA; Rajasingham R
    Clin Infect Dis; 2022 Oct; 75(9):1602-1609. PubMed ID: 35275989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fecal microbiota transplantation for refractory Clostridioides difficile infection with Crohn's disease in an allogeneic bone marrow transplant recipient].
    Tamura S; Ishida H; Shimizu T; Imaeda H; Nishida A; Bamba S; Andoh A; Iwasa Y; Kuroda H
    Rinsho Ketsueki; 2022; 63(3):217-223. PubMed ID: 35387936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of sequential fecal microbiota transplantation for fulminant Clostridioides difficile infection.
    Gupta S; Zhu J; McCarty TR; Pruce J; Kassam Z; Kelly C; Fischer M; Allegretti JR
    J Gastroenterol Hepatol; 2021 Sep; 36(9):2432-2440. PubMed ID: 33682170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors that Predict the Failure of Multiple Fecal Microbiota Transplantations for Clostridioides difficile Infection.
    Allegretti JR; Mehta SR; Kassam Z; Kelly CR; Kao D; Xu H; Fischer M
    Dig Dis Sci; 2021 Jan; 66(1):213-217. PubMed ID: 32170474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expert opinion on fecal microbiota transplantation for the treatment of
    Kumar V; Fischer M
    Expert Opin Biol Ther; 2020 Jan; 20(1):73-81. PubMed ID: 31690143
    [No Abstract]   [Full Text] [Related]  

  • 39. Pediatric Fecal Microbiota Transplantation in Recurrent
    Parnell JM; Nicholson MR; Kellermayer R; Kahn SA
    Pediatr Ann; 2021 Dec; 50(12):e515-e521. PubMed ID: 34889135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema.
    Lee CH; Belanger JE; Kassam Z; Smieja M; Higgins D; Broukhanski G; Kim PT
    Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1425-8. PubMed ID: 24627239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.